Twist Bioscience CEO, SVP, and insider sold shares post-Q2 loss, surpassing revenue estimates.
Twist Bioscience Co.'s (NASDAQ: TWST) CEO Emily Leproust, SVP Paula Green, and insider Dennis Cho sold shares of the company, with Leproust owning 499,593 shares and Green owning 88,837 shares post-transactions. Twist Bioscience's stock has a market cap of $2.58 billion and reported a Q2 loss of $1.47 per share, exceeding revenue estimates at $81.50 million. The company focuses on synthetic DNA-based products for various applications and has a consensus target price of $48.22.
August 10, 2024
3 Articles